Photo by Mikes Photos on Pexels.com

Top Searched Stocks on Wednesday


Why This Stock Was One of the Most Searched Stocks on Wednesday

By Glenford S. Robinson

According to Benzinga, this stock was one of the most searched stocks of the day on Wednesday, October 10, 2018. The people who were searching this stock knew something that the general public didn’t know. This kind of interest in a stock could be rumor-driven. As the saying goes “Buy the Rumor and Sell the News.”

Therefore, investors and traders could be loading up on this stock as a result of some underlying information that we are determine to find out. Let’s analyze this stock and see if we can come up with a reason for its high-flying action up the charts. The company we are referring to is called Nio Inc., a Chinese electric car maker, trading on the NYSE under the ticker symbol “NIO.”

According to the company’s profile, “Nio, Inc. designs, manufactures and sells smart and connected electric vehicles.” The company states that it builds autonomous driving electric vehicles integrated with artificial intelligence. In fact, one of its standout gems is the ES8, a seven-seater all aluminum alloy body electric sports utility vehicle (SUV), capable of accelerating from zero to 100 km in 4.4 seconds with a New European driving cycle driving range of up to 355 kilometers (km) and a maximum range of up to 500 km in a single charge.
One other electric car company comes to mind, Tesla.

I remembered when Tesla’s stock was hovering around $30 per share and many people weren’t paying much attention until it’s stock price sky rocketed to over $300 per share. Those people who weren’t paying much attention was obviously late to the dance. We can be rest assured that those nonbelievers are some of the people who are now buying Tesla shares at $300 per share.

We are now currently in a similar situation with Nio Inc. In fact, Nio’s stock is not even close to $30 per share like Tesla’s a couple years ago. Nio’s stock is currently only valued at $7.46 as of Friday, October 12, 2018, 4:06pm with a trading volume of 14,545,424. With such a high trading volume coupled with a high of $7.75 for the day and a low of $7.28, that is telling us that something big positively speaking is about to happened to the stock price in the not-so-distant future. This could have been the catalyst for the heightened interest in the stock and a reason why it was one of Benzinga’s top searched stocks on the day. Please formulate your own investment decision with the help of your investment advisor or financial advisor.

© 2018 mstardom.com. Mstardom Finance does not provide investment advice. All rights reserved.

Check Also

ECB profit increased in 2018

Financial Statements of the ECB for 2018

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor. Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

COURT ORDERS $1 BILLION JUDGMENT AGAINST OPERATORS OF WOODBRIDGE PONZI SCHEME TARGETING RETAIL INVESTORS

"This resolution accomplishes one of the SEC's core missions to protect retail investors," said Stephanie Avakian, Co-Director of the SEC's Division of Enforcement. "Mr. Shapiro and other defendants will be held accountable and required to pay substantial penalties for their misconduct." "Our complaint charged that when Woodbridge's fictitious business model collapsed, the company stopped paying investors and filed for Chapter 11 bankruptcy protection," said Eric I. Bustillo, Director of the SEC's Miami Regional Office. "The settlement provides for the return of significant funds to investors."

SEC Charges Cognizant and Two Former Executives With FCPA Violations

“Bribery to further corporate goals is an illusory path to long-term success. While always the wrong choice, it is particularly egregious when senior executives chart that course for those they lead, as our complaint alleges here. We are committed to holding them accountable for their actions,” said Charles E. Cain, Chief of the SEC Enforcement Division’s FCPA Unit.

%d bloggers like this: